TPG (Nasdaq: TPG) is a leading global alternative asset management firm, founded in San Francisco in 1992, with $229 billion of assets under management and investment and operational teams around the world. TPG invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, and market solutions, and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities.

Affirma Capital is an independent emerging market private equity firm owned and managed by the former senior leadership of Standard Chartered Private Equity (SCPE). The Founding Partners have worked together for over 16 years and currently manage over US$4 billion in assets for leading global limited partners. Affirma Capital helps build and nurture national and regional champions by investing in companies backed by strong management teams and founders. Throughout our 22 year history of investing in emerging markets we have deployed over US$6 billion in 99 companies across Asia, Africa and the Middle East and have returned over US$7 billion in cash proceeds to our investors at highly attractive rates of return. Our investment philosophy, focused on selective origination, disciplined deal structuring and intensive portfolio management, has helped us build a superior track record with realized returns at a significant premium to the MSCI Emerging markets index.

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. Vivo has approximately $5.4 billion in assets under management, invested in over 250 public and private companies worldwide. The firm is headquartered in Palo Alto, California, with additional offices in Asia. The Vivo team consists of more than 50 multi-disciplinary professionals, including, physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo provides a multi-fund investment platform, covering growth equity, private equity including buyout, venture capital, and public equity. Vivo invests broadly in healthcare across all fund strategies, including biotechnology, pharmaceuticals, medical devices, and healthcare services, with a focus on the largest healthcare markets.

TDR is a leading private equity firm with over €15 billion of assets under management and typically invests in strong European companies that are leaders in their markets. TDR has a 22-year track-record of working collaboratively with portfolio company management teams to deliver on a shared vision for growth and value creation, leveraging its investment, operational and data science expertise. TDR not only invests capital in portfolio companies, but also provides expert team resources to help bring about sustainable, positive and transformational change within its businesses.

STAR Capital is a private equity firm focused on developing strategic asset-based businesses in Western Europe. Established in 1999 and primarily investing in businesses with an enterprise value of between €50 million and €1 billion, our strategy is focused on businesses characterised by strategic qualities that provide strong downside protection.

For over 50 years Apax has worked to go beyond traditional private equity in building businesses. Results are driven by a collaborative culture that listens, learns and looks across horizons to inspire growth… together with partner companies. The firm conviction is that a blend of hands-on operating experience, specialist sector knowledge and incisive global perspective delivers best results. Working side-by-side with management teams, our goal is expanding mutual success through mutual vision.

Established in 1999, CapVest is a leading mid-market private equity firm headquartered in London. The Firm’s investment strategy is focused on identifying and managing investments in companies supplying essential goods and services. A patient investor, CapVest has established a strong record of success in delivering attractive returns by transforming the size and scale of its portfolio companies through a combination of organic and acquisition led growth.

We are one of the world's leading private asset growth investors, specialising in private equity, private credit, and following the ECP transaction, infrastructure. With €41bn of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market and sector expertise, consistently delivering strong returns through cycles.

BluePointe Ventures invests in founders who eschew frontier technology that is responsible for the fast changing human experience. Our investments range from AI based Bots to marketplaces to cloud based data center software. We relentlessly focus on leveraging our deep silicon valley tech network to support our founders achieve their dreams.

Charterhouse is one of the longest established private equity firms operating in Europe. The firm connects expertise and capital, partnering with ambitious founders and management teams to drive transformational change. Charterhouse has a selective, conviction-led approach to investing in high-quality mid-market European companies across the Services, Healthcare, Specialised Industrials and Consumer sectors. It targets transactions with an enterprise value of between €200m and €1.5bn. Charterhouse’s international team works in an integrated and flexible manner, allowing the firm to combine the skills, knowledge and experience of its entire team to help build successful businesses over the long term. The firm has completed more than 150 acquisitions over 35 years of activity in the European buyout market.